Quarterly report pursuant to Section 13 or 15(d)

Goodwill and intangible assets

v2.4.0.8
Goodwill and intangible assets
3 Months Ended
Oct. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Disclosure [Text Block]

Note 5 – Goodwill and intangible assets


At October 31, 2014 and July 31, 2014, the Company’s net carrying amount of goodwill, related to the Clinical Labs segment, is $7,452.


The Company’s change in the net carrying amount of intangible assets, all of which is included in the Life Sciences segment is as follows:


    Gross     Accumulated Amortization     Net  
July 31, 2014   $ 28,478     $ (20,370 )   $ 8,108  
Amortization expense           (431 )     (431 )
Foreign currency translation     (384 )     264       (120 )
October 31, 2014   $ 28,094     $ (20,537 )   $ 7,557  

Intangible assets consist of the following:


    October 31, 2014     July 31, 2014  
    Gross     Accumulated
Amortization
    Net     Gross     Accumulated
Amortization
    Net  
Patents   $ 11,027     $ (10,784 )   $ 243     $ 11,027     $ (10,775 )   $ 252  
Customer relationships     12,388       (6,712 )     5,676       12,602       (6,565 )     6,037  
Website and acquired content     1,024       (1,024 )           1,037       (1,037 )      
Licensed technology and other     524       (428 )     96       537       (434 )     103  
Trademarks     3,131       (1,589 )     1,542       3,275       (1,559 )     1,716  
Total   $ 28,094     $ (20,537 )   $ 7,557     $ 28,478     $ (20,370 )   $ 8,108  

At October 31, 2014, information with respect to intangibles assets acquired is as follows:


    Useful life
assigned
    Weighted average
remaining useful life
 
Customer relationships   8-15 years     6 years  
Trademarks   5 years     3 years  
Other intangibles   4-5 years     1 year  

At October 31, 2014, the weighted average useful lives of amortizable intangible assets were approximately five years.